Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.58 |
| ▸ | MAPT | P10636 | 4/20 | 0.58 |
| ▸ | POLB | P06746 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5952783 | 0.86 | TSHR (0.56) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL2776011 | 0.85 | MAPT (0.58) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL2929031 | 0.85 | TDP1 (0.62) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL12798874 | 0.85 | TDP1 (0.62) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL30989211 | 0.85 | TDP1 (0.62) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL11079242 | 0.83 | TDP1 (0.60) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL31423774 | 0.83 | TDP1 (0.60) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL2647110 | 0.83 | SKP2 (0.56) | TSHRTDP1MAPTPOLBALDH1A1 | |
| SCHEMBL10959235 | 0.82 | TSHR (0.55) | TSHRTDP1MAPTALDH1A1MEN1 | |
| SCHEMBL11539237 | 0.82 | TSHR (0.51) | TSHRTDP1MAPTPOLBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9287568-B2 | High performance, high durability non-precious metal fuel cell catalysts | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2016-03-15 | — | — | US | claimed |
| CN-101657921-B | High performance, high durability non-precious metal fuel cell catalysts | 3M INNOVATIVE PROPERTIES CO US | 2013-06-12 | — | — | CN | claimed |
| US-20110319257-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES COMPANY | 2011-12-29 | — | — | US | claimed |
| EP-2135313-B1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES CO (US) | 2011-09-14 | — | — | EP | claimed |
| CN-101657921-A | High-performance, high durability non-precious metal fuel cell catalysts | 3M INNOVATIVE PROPERTIES CO US | 2010-02-24 | — | — | CN | claimed |
| EP-2135313-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M Innovative Properties Company (US) | 2009-12-23 | — | — | EP | claimed |
| WO-2008127828-A1 | HIGH PERFORMANCE, HIGH DURABILITY NON-PRECIOUS METAL FUEL CELL CATALYSTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2008-10-23 | — | — | WO | claimed |
| CN-113828342-B | Cu-Pd-CeO 2 /γ-Al 2 O 3 Preparation of @ NP catalyst and synthesis of benzopyrazine compounds | 浙江工业大学 | 2022-10-11 | — | — | CN | disclosed |
| US-11396503-B2 | Sulfonyl substituted bicyclic compound which acts as ROR inhibitor | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2022-07-26 | — | — | US | disclosed |
| CN-111094267-B | Sulfonyl-substituted bicyclic compounds as ROR gamma inhibitors | 正大天晴药业集团股份有限公司 | 2022-06-14 | — | — | CN | disclosed |
| CN-113828342-A | Cu-Pd-CeO2/γ-Al2O3Preparation of @ NP catalyst and synthesis of benzopyrazine compounds | 浙江工业大学 | 2021-12-24 | — | — | CN | disclosed |
| EP-3891142-A1 | HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS | Boehringer Ingelheim International GmbH (DE) | 2021-10-13 | — | — | EP | disclosed |
| EP-3689860-A1 | SULFONYL-SUBSTITUTED BICYCLIC COMPOUND WHICH ACTS AS ROR INHIBITOR | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2020-08-05 | — | — | EP | disclosed |
| US-4230867-A | REDUCTION, CYCLIZATION OF NITROAZOBENZENES | CIBA-GEIGY CORPORATION (US) | 1980-10-28 | — | — | US | disclosed |
| US-4219480-A | REDUCTION OF UNDESIRED BY-PRODUCT AND EFFLUENT POLLUTION PROBLEMS | CIBA-GEIGY CORPORATION (US) | 1980-08-26 | — | — | US | disclosed |
| EP-0006564-A2 | 2-(3.5-disubstituted-2-hydroxyphenyl)-2H-benzotriazoles and stabilized compositions containing them | CIBA-GEIGY AG (CH) | 1980-01-09 | — | — | EP | disclosed |
| US-4141903-A | REDUCTION AND CYCLIZATION OF THE CORRESPONDING O-NITROAZOBENZENES WITH CARBON MONOXIDE USING A COPPER-AMINE COMPLEX AS CATALYST | CIBA-GEIGY CORPORATION (US) | 1979-02-27 | — | — | US | disclosed |
| US-4041044-A | BY REDUCTION OF CORRESPONDING O-NITRO-AZOBENZENES WITH ZINC IN AQUEOUS ALKALI METAL HYDROXIDE | CIBA-GEIGY CORPORATION (US) | 1977-08-09 | — | — | US | disclosed |
| US-3992378-A | HYPNOTIC AGENTS | ELI LILLY AND COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
| US-3962440-A | Quinoxaline compounds as hypnotic agents | ELI LILLY AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11396503-B2 | Sulfonyl substituted bicyclic compound which acts as ROR inhibitor | RORC, RORA, RORB | TSHR 421/4885TDP1 4768/4885MAPT 3807/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.